Trial Profile
Phase I/II trial of Ranpirnase in patients with HPV infections
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Ranpirnase (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- 25 Feb 2016 New trial record